COVID-19 vaccine approved for children over 6 months
No immediate information about distribution in Nunavut or Nunavik
Babies and preschoolers are now eligible to be vaccinated against COVID-19.
Health Canada’s website now says Moderna’s Spikevax vaccine is approved for the six-month to five-year age group, marking the first time young children have been able to get protection from the respiratory virus.
Moderna had applied in late April for authorization to administer its vaccine to children under six.
The website states that clinical trials conducted two weeks after administration of the second dose of the Moderna vaccine shows it’s 51 per cent effective in children ages six months to 23 months old, and 37 per cent effective in children ages two to five years.
Health Canada advises that young children should receive their first and second doses one month apart.
There was no immediate information about rollout of the Moderna vaccine in this age group in Nunavut or Nunavik.
Both jurisdictions rolled out vaccines for children aged five to 11 in November.
More to come…